We manufacture Bulk Active Pharmaceutical Ingredients (API) in full compliance with USA, European Union, Korean, Japanese and Bahamian Regulatory Authorities who regularly inspect the site.

​

The original site developed by Syntex Pharmaceuticals is located in Freeport, Grand Bahama on 70 acres of land in the city’s industrial area.

​

Since 2003 we have manufactured API of a leading antiretroviral for the fight against HIV-AIDS led by Gilead Sciences, building a proven track-record of quality and excellence in cGMP manufacturing.

​

In furtherance of this legacy, we are building a brand new state-of-the-art multi-purpose pharmaceutical fine chemical manufacturing facility for the production of both active ingredients and intermediates, supporting Gilead’s new pipeline while accommodating new products.

​

​

Beyond the production of API and intermediates, our expertise also includes:

​

• Analytical Validation

• Process Validation

• Commercial Scale-up from kilo lab to full-scale manufacturing

• Technical Transfer

• Project Management